BMC Pharmacology & Toxicology
Scope & Guideline
Fostering collaboration in pharmacology and toxicology.
Introduction
Aims and Scopes
- Pharmacokinetics and Drug Metabolism:
Research exploring how drugs are absorbed, distributed, metabolized, and excreted in biological systems. This includes studies on population pharmacokinetics and drug-drug interactions. - Toxicological Assessments:
Investigations into the adverse effects of drugs and chemicals on biological systems, including in vivo and in vitro studies that assess safety and toxicology. - Therapeutic Efficacy and Drug Development:
Studies evaluating the effectiveness of pharmacological agents in treating various conditions, including comparative studies of drug formulations and dosages. - Adverse Drug Reactions and Pharmacovigilance:
Research focused on monitoring and analyzing adverse drug reactions, utilizing databases like the FDA Adverse Event Reporting System to improve drug safety. - Innovative Drug Delivery Systems:
Development and evaluation of novel drug delivery methods, including nanotechnology-based approaches to enhance therapeutic outcomes. - Molecular Mechanisms of Drug Action:
Exploration of the cellular and molecular pathways affected by drugs, including studies on signaling pathways and gene expression related to pharmacological effects.
Trending and Emerging
- Integrated Pharmacovigilance Approaches:
There is an increasing trend towards comprehensive pharmacovigilance studies that leverage big data analytics and real-world evidence to monitor drug safety and adverse reactions. - Personalized Medicine and Pharmacogenomics:
Research focusing on the genetic factors that influence drug metabolism and response is gaining traction, emphasizing the importance of tailoring treatments to individual patient profiles. - Nanotechnology in Drug Delivery:
The application of nanotechnology for drug delivery systems is emerging as a significant area of research, aimed at improving the bioavailability and therapeutic efficacy of medications. - Investigating Drug Interactions:
A growing emphasis on understanding complex drug-drug interactions, particularly in polypharmacy settings, is evident, reflecting the need for safer therapeutic regimens. - Therapeutics in the Context of COVID-19:
Research addressing the pharmacological management of COVID-19, including the evaluation of existing drugs and the development of novel therapeutic agents, has surged in relevance. - Exploration of Natural Products and Traditional Medicine:
There is an increasing interest in the pharmacological properties of natural products, with studies assessing their potential therapeutic effects and safety profiles.
Declining or Waning
- Traditional Toxicology Studies:
There has been a noticeable reduction in studies focused solely on classical toxicology without integrating modern methodologies such as molecular biology techniques or advanced in vivo models. - In vitro Studies without Clinical Correlation:
Research that relies exclusively on in vitro models without subsequent validation in clinical or real-world settings is becoming less common, as there is a growing emphasis on translational research. - Single-Agent Pharmacology:
Research focusing solely on the effects of single drugs is declining, with a shift towards studies that explore drug combinations, polypharmacy, or drug interactions. - Animal Models with Limited Relevance to Human Health:
The use of animal models that do not adequately mimic human pathophysiology is less favored, leading to a decline in studies employing outdated or less relevant models. - Descriptive Epidemiology of Drug Use:
Research that simply describes drug use patterns without addressing the implications for pharmacotherapy or toxicology is waning, as the field moves towards more analytical and intervention-based research.
Similar Journals
Iranian Journal of Pharmaceutical Research
Championing excellence in pharmacological research and discovery.Welcome to the Iranian Journal of Pharmaceutical Research, a pioneering publication in the field of pharmacology, toxicology, and pharmaceutics, published by BRIEFLAND. Established in 2002, this journal has been a crucial platform for disseminating innovative research and scholarly articles, contributing significantly to the advancement of pharmaceutical sciences in Iran and beyond. With an impressive trajectory leading towards a convergence of knowledge by 2024, it proudly holds a Q3 ranking in Pharmacology (Medical) and a Q2 ranking in the broader realm of Pharmacology, Toxicology, and Pharmaceutics for 2023. The journal's influence is underscored by its Scopus rank of #25/80 in General Pharmacology, Toxicology, and Pharmaceutics, placing it within the 69th percentile, therefore appealing to researchers, professionals, and students alike. Although the journal operates under a non-open access model, it remains dedicated to providing high-quality research articles that explore the latest advancements in pharmaceutical sciences, making it an essential resource for anyone involved in this vibrant field of study.
JOURNAL OF PHARMACY AND PHARMACOLOGY
Fostering collaboration in the realm of drug discovery.Journal of Pharmacy and Pharmacology, published by Oxford University Press, is a prestigious academic journal dedicated to the advancement of knowledge in the fields of pharmaceutical sciences and pharmacology. With a strong heritage dating back to 1949, this journal maintains a robust influence, as evidenced by its ranking in the second quartile (Q2) across both Pharmaceutical Science and Pharmacology categories for 2023. The journal is accessible without an open access option, ensuring traditional academic engagement and providing valuable insights for researchers and professionals. It boasts an impressive Scopus ranking, with a percentile positioning of 72nd in Pharmaceutical Science and 67th in Pharmacology. Aimed at fostering innovative research and facilitating the exchange of cutting-edge scientific knowledge, the Journal of Pharmacy and Pharmacology serves as an essential resource for scientists, students, and healthcare professionals committed to enhancing therapeutic outcomes and advancing pharmaceutical innovations.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Delivering High-Impact Research for Healthcare ProfessionalsBASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, published by WILEY, serves as a vital resource in the fields of medicine, pharmacology, and toxicology. With an ISSN of 1742-7835 and E-ISSN 1742-7843, this journal has established a robust reputation, reflected in its Q2 classification across its categories in 2023. It aims to disseminate high-quality research and reviews that bridge the gap between basic scientific findings and clinical applications. Operating from the United States with an address at 111 RIVER ST, HOBOKEN 07030-5774, NJ, this journal focuses on the intersection of drug action and toxicity, making it an essential platform for researchers, healthcare professionals, and students. With a converged publication timeline from 2004 to 2024, BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY continues to make significant contributions to understanding pharmacological treatments and toxicological challenges. Open access options are available to broaden the reach and impact of its published work.
FUNDAMENTAL & CLINICAL PHARMACOLOGY
Advancing pharmacological knowledge for better health outcomes.FUNDAMENTAL & CLINICAL PHARMACOLOGY is a distinguished journal dedicated to advancing the fields of pharmacology and clinical medicine. Published by WILEY, this journal serves as a pivotal platform for researchers, healthcare professionals, and students alike to disseminate innovative research findings and clinical applications. With an impressive history spanning from 1987 to 2024, it has consistently maintained its relevance in the scientific community, evidenced by its Q2 quartile ranking in both Pharmacology and Pharmacology (medical) categories for 2023. The journal's diverse publication range, which includes original research articles, reviews, and clinical studies, helps bridge the gap between fundamental research and practical application in healthcare settings. Although it does not offer open access, its rigorous peer-review process ensures that published content meets the highest scholarly standards, making it a vital resource for those aiming to stay at the forefront of pharmacological sciences.
DRUG DEVELOPMENT RESEARCH
Unveiling breakthroughs in drug development for a healthier tomorrow.DRUG DEVELOPMENT RESEARCH is a premier interdisciplinary journal published by Wiley, focusing on the latest advancements in drug discovery, pharmacology, and toxicology. With an ISSN of 0272-4391 and an E-ISSN of 1098-2299, this esteemed publication has been a cornerstone in the field since its inception in 1981 and continues to provide cutting-edge research until 2024. Its rigorous peer-review process and strategic placement in Q2 of the Drug Discovery category, as well as ranking #60 out of 157 in Scopus, underscore the journal's relevance and influence, boasting a respectable 62nd percentile ranking. While the journal does not currently offer open access, it remains a vital resource for researchers, professionals, and students seeking to expand their knowledge on the processes of drug development, identifying new therapeutic targets, and assessing the efficacy and safety of novel compounds. Situated in Hoboken, NJ, this journal stands at the forefront of pharmaceutical innovation, making significant contributions to the advancement of medical science.
BIOLOGICAL & PHARMACEUTICAL BULLETIN
Advancing the Frontiers of Biomedicine and Drug DevelopmentBIOLOGICAL & PHARMACEUTICAL BULLETIN, published by the PHARMACEUTICAL SOC JAPAN, is a prominent peer-reviewed journal that serves the fields of medicine, pharmaceutical science, and pharmacology. With an ISSN of 0918-6158 and an E-ISSN of 1347-5215, this publication has been crucial in disseminating innovative research since its inception in 1993, and it continues to contribute significantly to the body of knowledge as it converges towards 2024. Despite being classified as a non-open access journal, it maintains a respectable Q3 ranking in Medicine (miscellaneous) and Q2 in Pharmaceutical Science, highlighting its critical role in advancing scientific discourse in these areas. With Scopus rankings placing it in the 51st percentile for Pharmaceutical Science and 38th percentile for Pharmacology, BIOLOGICAL & PHARMACEUTICAL BULLETIN is an essential resource for researchers, professionals, and students looking to stay abreast of cutting-edge developments and trends in biomedicine and drug development.
Frontiers in Pharmacology
Exploring innovative pathways in pharmacological research.Frontiers in Pharmacology, published by FRONTIERS MEDIA SA, stands as a leading open-access journal dedicated to advancing the field of pharmacology since its inception in 2010. With its ISSN 1663-9812, the journal is based in Switzerland and maintains a vital role in disseminating innovative research findings that span various disciplines within pharmacology, including pharmacokinetics, toxicology, and pharmacogenetics. In 2023, Frontiers in Pharmacology has achieved an impressive standing within the scientific community, being ranked in the Q1 category for both general and medical pharmacology, highlighting its critical contribution to the field with a Scopus ranking of #41 out of 272 in medical pharmacology and #76 out of 313 in pharmacology, toxicology, and pharmaceutics, placing it in the 75th and 85th percentiles, respectively. Researchers and practitioners benefit from its open-access model, which ensures widespread accessibility to groundbreaking research, fostering collaboration and innovation across the pharmaceutical sciences. With its commitment to excellence, Frontiers in Pharmacology serves as an essential resource for those looking to explore and contribute to the latest advancements in pharmacological research.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
Unveiling Innovations in Drug Action and TherapeuticsNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY is a prestigious journal published by SPRINGER, focusing on the dynamic fields of pharmacology and toxicology. With an ISSN of 0028-1298 and an E-ISSN of 1432-1912, this esteemed publication has been a staple in the scientific community since its inception in 1969, continuing to wield influence with a convergence of research that reaches through 2024. Ranked in the Q2 category for both medicine and pharmacology, it stands at an impressive 111th out of 313 in the Scopus rankings for pharmacology, reflecting its significant impact in the field. Though not offering open access, the journal remains a vital resource for researchers, professionals, and students seeking to explore groundbreaking studies and advancements in pharmacological science. With its high standards and comprehensive coverage, NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY is essential reading for those dedicated to understanding the mechanisms of drug action and the complexities of therapeutic interventions.
Journal of Pharmacological Sciences
Transforming research into therapeutic advancements.Journal of Pharmacological Sciences is a leading peer-reviewed academic journal dedicated to the field of pharmacology, published by the Japanese Pharmacological Society. Since its inception, this journal has offered an essential platform for the dissemination of high-quality research, contributing significantly to advancements in molecular medicine and pharmacology. With an impact factor that places it in the prestigious Q2 quartile for both categories, the journal has established itself as a credible source of innovative findings and methodologies since its transition to Open Access in 2015. This accessibility enables a broader audience, including researchers, healthcare professionals, and students, to engage with valuable insights and discussions pertinent to drug development, pharmacodynamics, and therapeutic strategies. Based in Kyoto, Japan, the journal serves as a vital resource for the global pharmacological community, encouraging collaboration and research that leads to improved health outcomes. For more information, submissions, and access to the latest research, visit the journal’s website.
INDIAN JOURNAL OF PHARMACOLOGY
Fostering excellence in pharmacology through rigorous inquiry.INDIAN JOURNAL OF PHARMACOLOGY, published by Wolters Kluwer Medknow Publications, is a premier platform dedicated to advancing the field of pharmacology and its related disciplines. With a rich history since its inception in 1978, this journal aims to disseminate high-quality research findings, reviews, and clinical studies that contribute to the global understanding of drug action and therapeutic practices. As a valuable resource for researchers, professionals, and students alike, it operates within the Q3 quartile of the Pharmacology category, positioning itself as an influential contributor in the realm of medical pharmacology. The journal is committed to publishing rigorous scientific inquiry, fostering innovation, and bridging gaps between laboratory research and clinical application. Readers can access its wide-ranging articles to stay informed about the latest advancements in the field, reflecting its crucial role in shaping future pharmacological research and practice.